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Abstract
Background: A major cellular change in dopaminergic neurons leading to Parkinsonism is the alteration 
of microtubule proteins that causes accumulation of tau protein, α-syn and β-amyloid plaque in the cells. In this 
study we investigate the role of Vitamin D3 in relieving the symptoms of Parkinsonism as it is capable of stimulating 
polymerization of microtubules. The Microtubules (MT) system in the fish scale melanocytes has been modeled for 
the dopaminergic neurons of the Substantia Nigra (SN). These cells are capable of forming cellular processes similar 
to what is seen in the dopaminergic neurons; in this study, we investigate the protective effect of Vitamin D3 Receptor 
Agonist (VDRA) and N-Methyl-D-Aspartate Receptor (NMDA R) inhibition in process formation, synaptic denervation 
and melanin loss in fish scale melanocytes modeled as pigmented adrenergic cells.
Method: The Tilapia scale was isolated and sub cultured in Ringer’s solution following which the cells were 
prepared for imaging. We incubated the cells with VDRA, Ketamine and a combination of Ketamine and VDRA in 
separate set ups for 60 minutes. Using brightfield imaging techniques, the cells were viewed during the incubation 
period and recorded using a Cameroscope connected to a computer interface.
Results/Conclusion: The cells incubated with VDRA and NMDA R inhibitor, showed an increase in the number 
of process and extent of the process formation; the increased number of process is an indication of a rapid rate of 
polymerization of microtubules. Also, the processes formed are combined long processes peculiar to the NMDA R1 
inhibition and short processes characteristic of VDR potentiation as seen in VDRA treatment only. Most of the effects 
of the VDRA were restricted to process formation around the cell body; this is similar to the microtubule cytoskeletal 
system found in the dendritic nucleation assembly. This finding confirms the presence of VDR and its likely restriction 
to d cell body plus its role in facilitating short dendrite-like process formation while NMDA R is located on the processes 
and facilitates long process formation.
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Introduction 
Selective vulnerability of the dopaminergic neurons and pigment 
cells of the SN cannot be over emphasized in the etiology and progression 
of PD. Deficiency of Vitamin D3 or genetic mutations involving the 
VDR have been described in multi array organ malfunction especially 
in the SN, parathyroid gland, bone and gastrointestinal tract [1,2]. 
Vitamin D3 Receptors (VDR) have been observed in the Substantia 
Nigra (SN) [3,4]; as well as in the skin and liver of the fish [5]. Our 
choice of the VDR and VDRA, in this study, is to establish in part, the 
cellular mechanism of Vitamin D3 as a neuroprotective agent in PD 
especially as it involves process formation and prevention of synaptic 
denervation via signaling pathways that facilitates polymerization of 
MT. The model used for this study involved melanocytes in Ringer’s 
solution containing NMDA R blocker ketamine; to induce process 
and synapse-like structure formation in these cells in vitro. Thus 
co-treatment, in vitro, with ketamine and Vitamin D3 (VDRA) 
describes the pharmacological action of NMDA R inhibition and VDR 
potentiation. The mechanism of the VDRA involves calcium signaling 
pathways that facilitate polymerization of MT such that the αβ-tubulin 
sub-units assemble and convey melanosomes and other vesicles to 
the periphery of the cell using the kinesin motor assembly [6]. This is 
believed to be complimentary to the inhibition of NMDA R; prevention 
of glutamate toxicity [7], as such movement of vesicles, away from the 
nucleus prevents cell death by autophagy.
The VDRA binds to a cytoplasmic receptor VDR having two 
domains; first is the hormone binding domain and second is the DNA 
binding domain. A VDR-VDRA receptor complex is formed and can 
bind to the promoter region of genes, thus increasing the rate of gene 
transcription and cellular activity [8]. Several studies have also shown 
that VDRAs are members of neuroactive steroids capable of regulating 
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several pathways important in neuronal development and function 
[9]. There is growing evidence that Vitamin D deficiency causes 
alteration in dopaminergic neurons in the adult brain [10]. Although 
the presence of the VDR have been described in the SN, there is no 
concrete evidence to describe the presence of this receptor in pigment 
cells or adrenergic cells and also no recorded evidence as to how they 
moderate cellular activities in the SN [11]. Other studies have shown 
that presence of corticosteroids like hydrocortisone did increase the 
gene transcription rate of VDR genes detected using RT-PCR; an act 
which is complementary in VDR up-regulation [12]. We are modeling 
the melanocytes in fish scale as the adrenergic neurons MT and 
pigment system [13,14]. In addition both cells are sites of action for 
catecholamines (epinephrine and nor epinephrine) and monoamines 
(Dopamine), thus we can deduce some information about signal 
transduction property of pigment cells endowed with special MT 
system for signal regulation and coordination [15].
The fish oil have also been found to be rich in Vitamin D3, as this oil 
has been found to be abundant in the skin of the fishes, also Vitamin D3 
receptors have been found in the brain, thus suggesting the relationship 
between MTs, melanocytes, neurons and Vitamin D3 activities [16]. 
Vitamin D3 is capable of stimulating MT activity and regulating the 
aggregation and dispersion of pigments in the scale of fishes, in the 
skin of humans. Deficiency of Vitamin D3 has been found to cause a 
disease called ricket, characterized with melanin patches on the skin, 
showing the dysregulation of proteins required for dispersion of 
melanin in the skin [17,18]. Vitamin D3 has also been observed to have 
a major influence in the exchange of calcium and phosphorus in the 
gastro intestinal tract and the Harvesian system of the bone [19]. This 
study is aimed at demonstrating melanocytes as a suitable model for 
MT and pigmented adrenergic cells of the Substantia Nigra (SN). The 
role of VDR potentiation and NMDA R inhibition was investigated in 
fish melanocytes; especially in the aspect of cellular process formation 
and synaptic denervation in the modeled pigment cells.
Methods
All reagents were procured from Sigma-Aldrich, Germany. The 
ketamine and Vitamin D3 were procured from Kanada Pharmaceuticals, 
Ekiti State, Nigeria.
Investigating MTs in fish scale in vitro
Freshly harvested fish scale (Tilapia) was placed in cold freshly 
prepared Ringer’s solution with the following composition; Sodium 
chloride: 8 g, Potassium Chloride: 0.42 g, Calcium Chloride: 0.24 g and 
0.20 g of Sodium bicarbonate. The solution was made up to 1,000 ml in 
double distilled water using the method of Singh and Lal [20].
Treatment and imaging
Vitamin D3 (VDRA) was used at a concentration of 1.5 micro/
Kg and NMDA R1 antagonist (ketamine) was used at a concentration 
of 25 µM. Four separate set ups were mad as follows; A: Ringers 
Solution, B: Ringers Solution+Ketamine, C: Ringers Solution+Vitamin 
D3+Ketamine, D: Ringers Solution+Vitamin D3. The process of cellular 
changes was recorded using a 5.1 MP Cameroscope connected to a 
bright field microscope (Olympus) and computer interface for live cell 
recording. No contrast media was added to the cultures; the cells were 
also unfixed. The culture was maintained by perfusion at an interval 
of 5 minutes and this was carried out for a maximum duration of 60 
minutes for each of the separate treatment categories (A, B, C and D).
Image acquisition
The images were rendered in gray scale using Image J (from NIH). 
Measurement of cellular processes was done by inverting the gray scale 
to create a white image on a dark background and to enhance contrast. 
The images were analyzed on Open Office Draw Suite (JAVA) to obtain 
the cell process lengths in micrometers (µm).
Results
The control cells were placed in Ringer’s solution only and showed 
no cellular changes after 60 minutes (Figure 1A and B). The cell bodies 
were condensed with less prominent projections. Inhibition of the 
NMDA R facilitated the formation of long cellular processes resembling 
axons (arrows; Figure 2A-2C). The cell bodies were reduced in size 
compared to the control having a pyramidal appearance (arrow head). 
The co-incubation of the cells with VDRA and ketamine (NMDA R 
antagonist), caused an increase in process formation (Figure 3A-
3C). The number or processes formed increased showing a rapid rate 
in polymerization of microtubules; also the processes formed are 
combined long processes peculiar to the NMDA R inhibition (Figure 3: 
yellow arrows) and short processes characteristic of VDRA treatment, 
as seen in VDRA treatment only (Figure 3: blue arrows). Most of the 
effect of the VDRA was restricted to process formation around the 
1A 1B 
Figure 1: (A-B): General morphology of the fish scale melanocyte in Ringer’s 
solution (60 minutes). The structure resembles that of undifferentiated migrating 
neurons (pigmented). The cells are capable of adrenergic cell response and 
the processes (arrow head) can extend when stimulated by environmental 
factors in counter shading and adaptive colouration (Magnification X100).
2A 2B 
2C 
Figure 2: (A-C): Effects of NMDA R1 antagonist Ketamine on the axo-
dendritic process formation response in melanocyte in vitro (2A-B). Ketamine 
was introduced into the culture solution for one hour to block NMDA R1, which 
induced axon-like process formation in the cells in culture (arrows; Figure 2A 
and B). (2C) Singly typed process formation in a small sized melanocyte; all 
the processes seen in  this cell are entirely axon-like projections (Magnification 
X100).
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cell body; this is similar to the microtubule cytoskeletal system found 
in the dendritic nucleation assembly of neurons.  These findings 
confirm the presence of VDR and its likely restriction to the cell 
body, and its role in facilitating short dendrite-like process formation 
while NMDA R is located on the processes and facilitates long axon-
like process formation. Sequel to combining VDRA treatment and 
NMDA R inhibition, the terminal parts of the long processes seen 
are characterized by blobbed ends rather than being straight endings 
observed in NMDA R inhibition only. Treatment with the VDRA 
only, facilitated the formation short cellular processes originating from 
the cell body (Figure 4A-4C). Morphometric analysis shows that the 
length of the processes observed in NMDA R inhibition is about 30 µm; 
while for the short processes observed in VDRA treatment are about 
10 µm in length (Figures 5B). In VDRA and NMDA R inhibition co-
treatment, the two forms of processes were observed, the number of 
process formed also increased significantly than what was observed in 
single treatments (Figure 5A). This further clarifies the separate roles 
of the two receptors as being responsible for different types of process 
formation in this cell model.
Discussion 
In several experiments, nocodazole (a common agent for 
depolymerizing MT)  has been described as a chemical substance 
capable of inducing cell death specifically by depolymerization of 
MTs and inhibition of the vesicular transport system, thus causing 
centralization of vesicles which in turns lead to autophagy [21]. Other 
studies describe the selective vulnerability of dopaminergic neurons 
to MT dependent degeneration [22,23]. To further elaborate on MT 
polymerization and depolymerization, epinephrine, norepinephrine 
and dopamine (adrenergic transmitters) are capable of inducing 
polymerization of microtubules through secondary messenger 
mechanism involving cyclic adenosine monophosphate (cAMP) 
[24,25]. In the melanocytes isolated from the Tilapia, epinephrine and 
cAMP drives assembly of motor proteins dyenin and kinesin from the 
Microtubule Organization Center (MTOC) for counter shading and 
adaptive coloration (aggregation versus dispersal of melanosomes) in 
the Tilapia [26]. We are thus anticipating that dopaminergic neurons 
may contain intrinsic pathways of generating epinephrine to drive a 
similar movement of melanin pigment in response to impulse from 
the association areas; similar to the findings of Nilsson and co-workers 
[27].
In fishes, signal is being transduced through the scales on the body 
surface and causes epinephrine dependent movement of melanosomes 
form the MTOC via motor proteins (kinesin and dyenin) [28,29]. 
Likening dopaminergic neurons to the melanocytes, they are not just 
neurons but specialized sensors of positions and environment [30]. 
The melanin pigments are most likely regulators of signal transduction 
in the entire movement coordination system of the brain, such that 
when nerve impulse passes, the Tubulin-motor protein complex are 
assembled from the MTOC or move pigments along their length in 
these neurons, thus generating specific information as to the nature of 
the movement and the extent of muscle contraction required for such 
movement [31]. This is also evident in the fishes as the scales have been 
found not to only contribute to the biological adaptation of fishes in 
water (counter shading) but senses the environment and contribute 
to movement and balance [32]. The loss of melanin pigments coupled 
with synaptic denervation have been implicated in the etiology of PD 
[3]. This can be studied using this model as depolymerization of the MT 
will cause centralization of all melanosomes being conveyed on such 
microtubule tracts. Aside having aggregation of malfolded MT proteins, 
accumulation of vesicles will induce cell death by autophagy [33]. In a 
similar way, synaptic denervation is a function of depolymerization of 
the axo-dendritic cytoskeletal structure [34]. In this study we have used 
Tilapia because it is readily available, the scales and cells are large and 
will require little magnification for clarity of melanocytes. The protein 
sequence for the MT protein is exact match with that of the rats and 
human models.
The role of VDR and NMDA R in such process formation cannot 
be over elucidated. NMDA R1 have been described as a specialized 
glutamate receptor that facilitate cell migration, process formation 
and synapse formation in developing neurons while VDR is capable 
of generating calcium based signal transduction which can facilitate 
3A 
3B 
3C 
Figure 3: (A-C):  Effects of NMDA R1 antagonist and Vitamin D3 co incubation 
in melanocytes treated for one hour. Cellular processes formed are indicated 
by arrows; both short (blue) and long processes (yellow) were formed 
following this treatment. VDR stimulation by VDRA favored the formation of 
short processes taking origin directly from the cell body. The short processes 
(yellow arrows) are highly branched while the long processes (blue arrows) 
are blobbed at the terminal parts (Magnification X100).
4A 
4C 
4B 
Figure 4: (A-C): VDRA induces short process formation (4A-B). The process 
formation pattern is similar to dendrite formation in neurogenesis. Cell polarity 
is seen and symmetry is a major feature of the cells in this category of 
treatment. When compared to Figure 4C (Ketamine treatment) the processes 
are longer and migrates over a longer distance away from the cell body. The 
cell body is also relatively reduced in the ketamine treatment (yellow arrow) 
(Magnification X100).
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polymerization of microtubules; although the function of the NMDA 
R differ slightly in the developing and adult neurons [35-37]. 
The studies of Cui et al. [38], suggests that VDR is abundant in 
dopamine rich regions of the brain, also highly hydroxylase positive 
neurons in humans expressed VDR. Deficiency of Vitamin D or loss 
of VDR is usually associated with risk of several neurodevelopmental 
disorders to loss of antiproliferative functions, thus the absence of VDR 
or VitD3 deprives the neurons of needed signals. The studies of Suzuki 
et al. [39] also corroborated this finding that Vitamin D deficiency is a 
predisposing factor to increased progression of PD. The findings of this 
study suggest that the progression of such disease conditions is related 
to process formation and synaptic denervation. This study further 
elaborates the cellular mechanism involved in the disease progression. 
This study however shows that inhibition of the NMDA R did facilitate 
the formation of long axon-like processes extending between two 
adjacent melanocytes, while the VDR stimulation caused short process 
formation radiating from the cell body and representing an array of 
bi-directional vesicular transport system. Similar to our proposition in 
this study, Aspengren et al. [40] suggested that Melanocytes develop 
from the neuronal crest and are most abundant in the dermal and 
epidermal layers of the skin, where the intracellular distribution of the 
pigment significantly influences the color of the animal. The transport 
of pigment is dependent on an intact cytoskeleton and motor proteins 
associated with cytoskeletal components. From a neuroscience 
perspective, other studies have also shown that axon dendrite process 
formation is differentially affected [36]. The control cells were placed 
in Ringer’s solution and showed no cellular changes (Figure 1A and 
B). The cell bodies are condensed with less prominent projections. 
Inhibition of the NMDA R facilitated the formation of long cellular 
processes resembling the axons (Figure 2A-2C). The cell bodies were 
reduced in size compared to the control having a pyramidal appearance 
(arrow head). Adjacent cells also maintained temporary contact similar 
to what is obtainable in neuronal synapse formations.
Conclusion
The co incubation of the cells with VDRA and NMDA R 
inhibitor, Showed an increase in process formation. The number or 
processes formed increased showing a rapid rate in polymerization of 
microtubules; also the processes formed are combined long processes 
peculiar to the ketamine treatment and short processes characteristic 
of VDR treatment as seen in VDRA treatment only. Most of the effects 
of the VDRA were restricted to process formation around the cell 
body; this is similar to the microtubule cytoskeletal system found in the 
dendritic nucleation assembly. This finding confirms the presence of 
VDR and its likely restriction to d cell body plus its role in facilitating 
short dendrite like process formation while NMDA R is located on the 
processes and facilitates long process formation; similar to the findings 
of Beckerman et al. [37].
Research Summary
Parkinson’s disease (and other associated movement disorders) is a 
common condition that is triggered by chemical, environmental, genetic 
and neurotrophic factors in which dopaminergic neurons are lost and 
melanin pigment is reduced in the SN. If not treated, it can progress 
rapidly into movement disorders and other cognitive dysfunctions. 
Since the initial description of this disease and other NDD’s, efforts 
have been directed towards understanding the molecular mechanism 
of pigment loss and cell death in the SN. The cause of PD has been 
broadly described as unclear; in addition loss of adrenergic cells have 
also been described in the progression of the diseases condition which 
is characterized by shortening of neuronal projection as a form of 
synaptic denervation. However, to understand the process involved 
in this synaptic denervation of adrenergic pigmented neurons, the 
molecular mechanism needs to be studied at cell and protein level.
Results
In this study, we have first described the mechanism involved 
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Figure 5: (A-B): Inverted gray scale cell process measurement for Control 
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process length was observed in all the treatment categories. Ketamine 
treatment gave the longest cell process while VDRA treatment induced shorter 
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Ketamine Treatment).
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in neuronal loss in the SN and the general structure of the fish scale 
melanocyte. Using bright field imaging techniques, live cell imaging 
was conducted in vitro to show the various changes observed in the 
melanocytes upon manipulation of the NMDA R and the VDR.  The 
outcome shows that the fish scale melanocyte contains NMDA R on 
its membrane just like the human neuronal cells, although it is much 
more localized on the axon-like processes; while VDR is localized on 
the cell body and short dendrite-like processes. Upon inhibition of 
this receptor (using ketamine; a human NMDA R antagonist), the cell 
projections forms wide array networks of cellular processes following 
a similar pattern to what is observed in neuronal axon-dendrite 
formation. Glutamate treatment (NMDA R potentiation) also caused 
formation of cellular projections but not as extensive as that seen in 
NMDA R inhibition. These findings therefore creates a premise for 
the study of pigmented neuronal cells in vitro as this cell type (fish 
scale melanocyte) expresses NMDA R and the role of this receptor 
in cellular process formation has also been seen to be similar to the 
pattern observed in neuronal axon-dendrite formation. Inverted gray 
scale image analysis shows that this cell upon inhibition of NMDA 
R shows temporary connections between the formed processes, an 
association similar to the synapse that has been observed in the human 
neurons. VDR stimulation facilitated more of short process formation 
radiating directly from the cell body suggesting its role in cellular 
process formation similar to that of the dendritic nucleation assembly 
in neurons.
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